86 related articles for article (PubMed ID: 15927092)
1. Corneal temperature in schizophrenia patients.
Shiloh R; Munitz H; Portuguese S; Gross-Isseroff R; Sigler M; Bodinger L; Katz N; Stryjer R; Hermesh H; Weizman A
Int J Neuropsychopharmacol; 2005 Dec; 8(4):537-47. PubMed ID: 15927092
[TBL] [Abstract][Full Text] [Related]
2. Association between corneal temperature and mental status of treatment-resistant schizophrenia inpatients.
Shiloh R; Schapir L; Bar-Ziv D; Stryjer R; Konas S; Louis R; Hermesh H; Munitz H; Weizman A; Valevski A
Eur Neuropsychopharmacol; 2009 Sep; 19(9):654-8. PubMed ID: 19493658
[TBL] [Abstract][Full Text] [Related]
3. Lower corneal temperature in neuroleptic-treated vs. drug-free schizophrenia patients.
Shiloh R; Bodinger L; Katz N; Sigler M; Stryjer R; Hermesh H; Munitz H; Weizman A
Neuropsychobiology; 2003; 48(1):1-4. PubMed ID: 12886032
[TBL] [Abstract][Full Text] [Related]
4. Increased corneal temperature in drug-free male schizophrenia patients.
Shiloh R; Portuguese S; Bodinger L; Katz N; Sigler M; Hermesh H; Munitz H; Weizman A
Eur Neuropsychopharmacol; 2003 Jan; 13(1):49-52. PubMed ID: 12480122
[TBL] [Abstract][Full Text] [Related]
5. Acute antipsychotic drug administration lowers body temperature in drug-free male schizophrenic patients.
Shiloh R; Hermesh H; Weizer N; Dorfman-Etrog P; Weizman A; Munitz H
Eur Neuropsychopharmacol; 2000 Dec; 10(6):443-5. PubMed ID: 11115733
[TBL] [Abstract][Full Text] [Related]
6. Altered thermoregulation in ambulatory schizophrenia patients: a naturalistic study.
Shiloh R; Weizman A; Stryjer R; Kahan N; Waitman DA
World J Biol Psychiatry; 2009; 10(2):163-70. PubMed ID: 19514098
[TBL] [Abstract][Full Text] [Related]
7. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
[TBL] [Abstract][Full Text] [Related]
8. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients.
Shiloh R; Valevski A; Bodinger L; Misgav S; Aizenberg D; Dorfman-Etrog P; Weizman A; Munitz H
Int Clin Psychopharmacol; 2003 May; 18(3):147-9. PubMed ID: 12702893
[TBL] [Abstract][Full Text] [Related]
9. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
Himei A; Okamura T
Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
[TBL] [Abstract][Full Text] [Related]
11. Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions.
Delieu JM; Horobin RW; Duguid JK
J Psychopharmacol; 2006 Nov; 20(6):824-8. PubMed ID: 16401649
[TBL] [Abstract][Full Text] [Related]
12. Towards an animal model of an antipsychotic drug-resistant cognitive impairment in schizophrenia: scopolamine induces abnormally persistent latent inhibition, which can be reversed by cognitive enhancers but not by antipsychotic drugs.
Barak S; Weiner I
Int J Neuropsychopharmacol; 2009 Mar; 12(2):227-41. PubMed ID: 18687163
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics.
Zhang XY; Tan YL; Cao LY; Wu GY; Xu Q; Shen Y; Zhou DF
Schizophr Res; 2006 Jan; 81(2-3):291-300. PubMed ID: 16309894
[TBL] [Abstract][Full Text] [Related]
14. Excitability of the motor cortex in schizophrenia following typical and atypical antipsychotics: two serial case reports.
Puri BK; Davey NJ; Zaman R
Int J Clin Pract; 2003 Nov; 57(9):831-3. PubMed ID: 14686575
[TBL] [Abstract][Full Text] [Related]
15. Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.
Tan YL; Zhou DF; Cao LY; Zou YZ; Zhang XY
Neurosci Lett; 2005 Jul 1-8; 382(1-2):27-32. PubMed ID: 15911116
[TBL] [Abstract][Full Text] [Related]
16. Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions.
Gaebel W; Riesbeck M; Janssen B; Schneider F; Held T; Mecklenburg H; Sass H
Eur Arch Psychiatry Clin Neurosci; 2003 Aug; 253(4):175-84. PubMed ID: 12910348
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics cause an acute increase in cutaneous hand blood flow in patients with schizophrenia and schizoaffective disorder.
Blessing E; Kader L; Arpandy R; Ootsuka Y; Blessing WW; Pantelis C
Aust N Z J Psychiatry; 2011 Aug; 45(8):646-53. PubMed ID: 21870922
[TBL] [Abstract][Full Text] [Related]
18. Heat intolerance in patients with chronic schizophrenia maintained with antipsychotic drugs.
Hermesh H; Shiloh R; Epstein Y; Manaim H; Weizman A; Munitz H
Am J Psychiatry; 2000 Aug; 157(8):1327-9. PubMed ID: 10910799
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of schizophrenia spectrum disorders in relatives of neuroleptic-nonresponsive schizophrenic patients.
Joober R; Rouleau GA; Lal S; Bloom D; Lalonde P; Labelle A; Benkelfat C
Schizophr Res; 2005 Sep; 77(1):35-41. PubMed ID: 16005383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
